WorldCat Identities

Visciano, Maria Luisa

Overview
Works: 7 works in 7 publications in 1 language and 12 library holdings
Roles: Author, Contributor
Publication Timeline
.
Most widely held works by Maria Luisa Visciano
Effects of adjuvants on IgG subclasses elicited by virus-like Particles by Maria Luisa Visciano( )

1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses by Hualin Li( )

1 edition published in 2006 in English and held by 2 WorldCat member libraries worldwide

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate by NGIN Consortium( )

1 edition published in 2013 in English and held by 2 WorldCat member libraries worldwide

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response by Maria Luisa Visciano( )

1 edition published in 2008 in English and held by 2 WorldCat member libraries worldwide

Characterization of Antibodies That Inhibit HIV gp120 Antigen Processing and Presentation by Maria Luisa Visciano( )

1 edition published in 2005 in English and held by 2 WorldCat member libraries worldwide

Development and immunological evaluation of particulate antigenic approaches to HIV : tesi di dottorato di ricerca in basic and applied immunology by Maria Luisa Visciano( Book )

1 edition published in 2012 in English and held by 1 WorldCat member library worldwide

Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration by Luigi Buonaguro( )

1 edition published in 2012 in English and held by 1 WorldCat member library worldwide

Female rhesus macaques were immunized with HIV virus-like particles (HIV-VLPs) or HIV DNA administered as sequential combinations of mucosal (intranasal) and systemic (intramuscular) routes, according to homologous or heterologous prime-boost schedules. The results show that in rhesus macaques only the sequential intranasal and intramuscular administration of HIV-VLPs, and not the intranasal alone, is able to elicit humoral immune response at the systemic as well as the vaginal level
 
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.97 (from 0.96 for Immunogeni ... to 0.98 for Developmen ...)

WorldCat IdentitiesRelated Identities
Languages